Literature DB >> 25211853

Ophthalmic beta blockers: treatment for acute migraine?

J Kent Dexter, Roger K Cady.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25211853      PMCID： PMC6179475     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


× No keyword cloud information.
  8 in total

1.  Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report.

Authors:  N T Mathew; J Kailasam; L Meadors; O Chernyschev; P Gentry
Journal:  Headache       Date:  2000-10       Impact factor: 5.887

Review 2.  Mechanisms of action of the 5-HT1B/1D receptor agonists.

Authors:  Stewart J Tepper; Alan M Rapoport; Fred D Sheftell
Journal:  Arch Neurol       Date:  2002-07

3.  Migraine diagnosis and treatment: results from the American Migraine Study II.

Authors:  R B Lipton; S Diamond; M Reed; M L Diamond; W F Stewart
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

4.  Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Authors:  M D Ferrari; K I Roon; R B Lipton; P J Goadsby
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

5.  Preventive pharmacologic treatments for episodic migraine in adults.

Authors:  Tatyana A Shamliyan; Jae-Young Choi; Rema Ramakrishnan; Jennifer Biggs Miller; Shi-Yi Wang; Frederick R Taylor; Robert L Kane
Journal:  J Gen Intern Med       Date:  2013-04-17       Impact factor: 5.128

6.  Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.

Authors:  Marcelo Bigal; Alan Rapoport; Sheena Aurora; Fred Sheftell; Stewart Tepper; Carl Dahlof
Journal:  Headache       Date:  2007-04       Impact factor: 5.887

7.  Advances in drug development for acute migraine.

Authors:  Ryan J Cady; Candace L Shade; Roger K Cady
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

8.  Beta-blocker migraine prophylaxis affects the excitability of the visual cortex as revealed by transcranial magnetic stimulation.

Authors:  Marcus Gerwig; L Niehaus; P Stude; Z Katsarava; H C Diener
Journal:  J Headache Pain       Date:  2011-11-17       Impact factor: 7.277
  8 in total
  2 in total

1.  It Should Not Be This Difficult to Engage Pharma in an Effective, Safe, Inexpensive Product for Acute Migraine, the Third Most Prevalent Disease in the World.

Authors:  John C Hagan
Journal:  Mo Med       Date:  2022 Jan-Feb

2.  A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.

Authors:  Dipika Aggarwal; Andrew J Heim; Brennen Bittel; Deetra Ford; Richard Dubinsky; Gary Gronseth; Vernita Hairston; Patrick Landazuri; Fred Sachen; Laura Herbelin; Richard J Barohn
Journal:  Kans J Med       Date:  2020-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.